{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-073229","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2022-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.975087+00:00","generated_at":"2026-06-21T17:47:21.080373+00:00","sec_items":["1.01","7.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ASP Isotopes closes IPO of 1.25M shares at $4.00, raising $5.0M gross; listed on Nasdaq","bullets":["Closed IPO of 1,250,000 shares of common stock at $4.00/share for aggregate gross proceeds of $5.0M.","Shares began trading on Nasdaq Capital Market on Nov 10, 2022 under ticker ASPI.","Underwriters have 45-day over-allotment option to purchase up to 187,500 additional shares at $4.00.","Net proceeds to be used to complete Molybdenum enrichment facility in Pretoria, South Africa and for general corporate purposes.","Revere Securities LLC acted as sole book-running manager for the offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-073229","json":"https://secwatch.observer/filing/0001213900-22-073229.json","markdown":"https://secwatch.observer/filing/0001213900-22-073229.md","text":"https://secwatch.observer/filing/0001213900-22-073229.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000121390022073229/0001213900-22-073229-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000121390022073229/ea168737-8k_aspisotopes.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T17:47:21.080373+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"779243b7932ac6a55f3e4fb7003157552b15be5c","claim":"ASP Isotopes Inc. entered into Underwriting Agreement with Revere Securities LLC (effective 2022-11-09).","evidence_excerpt":"On November 9, 2022, ASP Isotopes Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Revere Securities LLC, as representative of the several underwriters identified therein (the “Underwriters”), relating to the public offering (the “Offering”) of 1,250,000 shares of the Company’s common stock (the “Shares”) by the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1921865/000121390022073229/0001213900-22-073229-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Revere Securities LLC"},{"label":"Effective","value":"2022-11-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}